Ligand validation:6HFN

DOR: (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE-4-CARBOXYLIC ACID

DOR is a Ligand Of Interest in 6HFN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HFN_DOR_A_1907	77%	17%	0.097	0.935	1.44	2.18	2	1	0	0	100%	0.732
4C6D_DOR_A_2822	98%	21%	0.058	0.98	1.39	1.93	1	3	4	0	100%	0.45
4C6I_DOR_A_2830	98%	24%	0.062	0.982	1.4	1.7	1	1	3	0	100%	0.41
4C6E_DOR_A_1410	95%	21%	0.076	0.978	1.38	1.9	1	2	4	0	100%	0.51
4C6F_DOR_A_1410	93%	21%	0.083	0.98	1.49	1.84	2	1	4	0	100%	0.38
9FS2_DOR_A_1905	93%	11%	0.062	0.955	2.92	1.27	5	1	0	0	100%	0.443
6ET4_DOR_A_502	99%	5%	0.048	0.983	2.15	3.09	5	6	0	0	100%	1
6GK0_DOR_A_502	98%	10%	0.065	0.988	1.83	2.48	4	6	0	0	100%	1
2E68_DOR_B_2353	97%	26%	0.059	0.976	1.04	1.92	-	4	1	0	100%	1
3KVK_DOR_A_399	96%	14%	0.075	0.984	1.39	2.46	1	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.